UVFT (UV Flu Technologies) ROC (Joel Greenblatt) %: -1,318.52% (As of Mar. 2016)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is UV Flu Technologies ROC (Joel Greenblatt) %?

UV Flu Technologies UVFT ROC (Joel Greenblatt) % is -1,318.52% as of Mar. 2016.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. UV Flu Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2016 was -1,318.52%.

The historical rank and industry rank for UV Flu Technologies's ROC (Joel Greenblatt) % or its related term are showing as below:

UVFT's ROC (Joel Greenblatt) % is not ranked *
in the Industrial Products industry.
Industry Median: 11.73
* Ranked among companies with meaningful ROC (Joel Greenblatt) % only.

UV Flu Technologies's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


UV Flu Technologies  (OTCPK:UVFT) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


UV Flu Technologies ROC (Joel Greenblatt) % Related Terms


UV Flu Technologies ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for UV Flu Technologies's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UV Flu Technologies ROC (Joel Greenblatt) % Chart

UV Flu Technologies Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only -869.35 -408.86 -410.81 -814.91 -2,495.77

UV Flu Technologies Quarterly Data
Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,371.43 -1,969.23 -3,698.36 -1,958.62 -1,318.52

UVFT vs PCTL, DSOX, CDTI: ROC (Joel Greenblatt) % Comparison

For the Pollution & Treatment Controls subindustry, UV Flu Technologies's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UV Flu Technologies ROC (Joel Greenblatt) % vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, UV Flu Technologies's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where UV Flu Technologies's ROC (Joel Greenblatt) % falls into.



UV Flu Technologies ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2015 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.101 + 0.043 + 0.021) - (0.377 + 0 + 0.057)
=-0.269

Working Capital(Q: Mar. 2016 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.06 + 0.067 + 0.058) - (0.446 + 0 + 0.091)
=-0.352

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of UV Flu Technologies for the quarter that ended in Mar. 2016 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2016 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2015  Q: Mar. 2016
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.356/( ( (0.028 + max(-0.269, 0)) + (0.026 + max(-0.352, 0)) )/ 2 )
=-0.356/( ( 0.028 + 0.026 )/ 2 )
=-0.356/0.027
=-1,318.52 %

Note: The EBIT data used here is four times the quarterly (Mar. 2016) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -1,318.52% mean?
UV Flu Technologies (UVFT) has a ROC (Joel Greenblatt) % of -1,318.52% as of Mar. 2016. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on UV Flu Technologies and its competitors.
Is UV Flu Technologies' ROC (Joel Greenblatt) % too high?
UV Flu Technologies' current ROC (Joel Greenblatt) % is -1,318.52%.
How does UV Flu Technologies' ROC (Joel Greenblatt) % compare to PCTL and DSOX?
UV Flu Technologies' ROC (Joel Greenblatt) % of -1,318.52% can be compared against companies in the Industrial Products industry. The industry median ROC (Joel Greenblatt) % is 11.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for an Industrial Products company?
The median ROC (Joel Greenblatt) % among Industrial Products companies is 11.73, based on 3,060 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on UV Flu Technologies and its competitors. For the Industrial Products industry, the median ROC (Joel Greenblatt) % is 11.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UV Flu Technologies's current ROC (Joel Greenblatt) % is -1,318.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UV Flu Technologies stock overvalued right now?
UV Flu Technologies (UVFT) has a current ROC (Joel Greenblatt) % of -1,318.52%. The current ROC (Joel Greenblatt) % is -1,318.52%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For UV Flu Technologies (UVFT), the current ROC (Joel Greenblatt) % is -1,318.52% as of Mar. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

UV Flu Technologies Business Description

Address 250 Parkway Drive, Suite 150, Lincolnshire, IL, USA, 60069
UV Flu Technologies Inc is a manufacturer of the finest air purification systems. In addition, it also acts as a developer, manufacturer, and distributor of biotechnology products targeting the rapidly growing Indoor Air Quality industry sector. The company's flagship product is the ViraTech-RX-400 model which utilizes high-intensity germicidal ultraviolet radiation inside a killing chamber that goes beyond filtering to destroy harmful bacteria. All of UV Flu's products are manufactured in the United States of America.